03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Palbocap 125mg : | |
Type | Medicine Pending |
Originator | Ibrance Capsules 125mg |
Agent | Lebiran |
Distributor | Lebiran |
Laboratory | Sobhan Darou |
Manufacturer | Pfizer Pharmaceutical LLC |
Manufacturing Type | G |
Origin | U.S.A. |
ATC | L01XE33 |
Palbocap 125mg :
Palbocap 125mg :
Palbocap 125mg :
Palbocap 125mg :
Palbocap 125mg :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Alopecia | Very Common |
ALT increased | Common |
Anaemia | Very Common |
Aphthous stomatitis | Very Common |
AST increased | Common |
Asthenia | Common |
Cheilitis | Very Common |
Decreased appetite | Very Common |
Dermatitis | Very Common |
Dermatitis acneiform | Very Common |
Diarrhoea (Diarrhea) | Very Common |
Dry eye | Common |
Dry skin | Common |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Common |
Epistaxis (Nasal bleeding) | Common |
Fatigue | Very Common |
Febrile neutropenia (Neutropenic fever) | Common |
Glossitis | Very Common |
Glossodynia | Very Common |
Haematocrit decreased | Very Common |
Haemoglobin decreased | Very Common |
Infections various | Very Common |
Lacrimation increased (Epiphora) | Common |
Leucopenia (Leukopenia) | Very Common |
Leukocyte count decreased (White blood cell count decreased) | Very Common |
Maculopapular rash | Very Common |
Mouth ulceration | Very Common |
Mucosal inflammation | Very Common |
Nausea | Very Common |
Neutropenia | Very Common |
Neutrophil count decreased | Very Common |
Oral pain | Very Common |
Oropharyngeal discomfort | Very Common |
Oropharyngeal pain | Very Common |
Platelet count decreased (Thrombocyte count decreased) | Very Common |
Pyrexia | Common |
Rash erythematous | Very Common |
Rash papular | Very Common |
Rash pruritic | Very Common |
Skin rash | Very Common |
Stomatitis | Very Common |
Thrombocytopenia (Thrombopenia) | Very Common |
Toxic skin eruption | Very Common |
Vision blurred | Common |
Vomiting | Very Common |
▲ Most Expensive |
▼ Least Expensive |
P.P. = | Public Price |
P/U = | Price Per Unit |
- Products with same active ingredients |
- Products with same strength |
- Products with same route of administration |
NB : Products With Same Indication |
Different Units By MoH Code
Palbocap 125mg MoH 2064373 :
Form | Capsule, hard |
Packaging | Blisters (Al/PVC/PE/PCTFE) |
Package Size | Box of 21 |
Strength | 125mg |
Storage Condition | <30°C None |
Stratum | N/A |
NSSF | ✘ |
Quarantine | ✘ |
Submission date | 11/08/2020 |
Pending Year | 06/11/2020 |
Pending Reason | Incomplete file |
Price Comparison
You have to register to view this info
Drop File